Tag: lexaria bioscience corp

October 8, 2019

Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria

Lexaria is pleased to provide this update on the ongoing relationship and pursuit of innovation in oral, reduced risk nicotine...
October 2, 2019

Smart Cannabis Vaporizers Empowering Physicians and Patients

Without accurate and reliable dosing, medical cannabis won’t make the pharmaceutical grade.
August 27, 2019

Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce...
August 21, 2019

Lexaria Announces Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil

Lexaria Bioscience Corp. (OTC:LXRP, CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce...
August 15, 2019

Lexaria Bioscience Announces it has Received Four New Patents

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce...
August 14, 2019

Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce...
August 13, 2019

Lexaria Bioscience Receives Cannabis R&D License from Health Canada

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce...